Other than hypoxia, many genetic alterations inactivating tumor suppressors or activating oncoproteins have been reported to increase the basal levels of HIF-1α in cancers and contribute to tumor progression and angiogenesis [17]. The gene discussed is HIF1A; the disease is neoplasm.